| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza A Virus, H7N9 Subtype | 2 | 2017 | 415 | 0.98 | Why? |
| Evolution, Molecular | 5 | 2021 | 3691 | 0.78 | Why? |
| Hemagglutinins | 2 | 2019 | 143 | 0.76 | Why? |
| Antigenic Variation | 2 | 2017 | 249 | 0.76 | Why? |
| Influenza A Virus, H3N2 Subtype | 3 | 2019 | 572 | 0.70 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2017 | 492 | 0.65 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2017 | 511 | 0.62 | Why? |
| Hemagglutinins, Viral | 1 | 2017 | 176 | 0.61 | Why? |
| Neuraminidase | 1 | 2017 | 289 | 0.59 | Why? |
| Genome, Viral | 6 | 2021 | 13157 | 0.47 | Why? |
| Influenza A virus | 3 | 2017 | 2234 | 0.41 | Why? |
| Virus Attachment | 1 | 2017 | 1259 | 0.40 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2019 | 2984 | 0.37 | Why? |
| Computational Biology | 5 | 2020 | 4514 | 0.35 | Why? |
| Phylogeny | 4 | 2021 | 13341 | 0.33 | Why? |
| Sequence Analysis, DNA | 1 | 2016 | 2830 | 0.33 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.31 | Why? |
| Antigens, Viral | 3 | 2019 | 6298 | 0.30 | Why? |
| Epidemiological Monitoring | 1 | 2016 | 3493 | 0.25 | Why? |
| Influenza, Human | 3 | 2017 | 10779 | 0.24 | Why? |
| Morphogenesis | 1 | 2020 | 43 | 0.22 | Why? |
| DNA Transposable Elements | 2 | 2017 | 91 | 0.21 | Why? |
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2019 | 2 | 0.20 | Why? |
| Embryonic Development | 1 | 2019 | 55 | 0.20 | Why? |
| Embryo, Mammalian | 1 | 2019 | 86 | 0.20 | Why? |
| Blastocyst | 1 | 2019 | 65 | 0.19 | Why? |
| Mutation | 4 | 2021 | 12376 | 0.19 | Why? |
| Cephalopoda | 1 | 2017 | 1 | 0.18 | Why? |
| Aliivibrio fischeri | 1 | 2017 | 1 | 0.18 | Why? |
| Symbiosis | 1 | 2017 | 38 | 0.18 | Why? |
| Mycobacterium Infections | 1 | 2018 | 72 | 0.18 | Why? |
| Fas Ligand Protein | 1 | 2017 | 69 | 0.18 | Why? |
| Embryonic Stem Cells | 1 | 2017 | 66 | 0.18 | Why? |
| Bacteroides | 1 | 2017 | 16 | 0.18 | Why? |
| Prokaryotic Cells | 1 | 2017 | 15 | 0.17 | Why? |
| Melanoma, Experimental | 1 | 2017 | 57 | 0.17 | Why? |
| fas Receptor | 1 | 2017 | 85 | 0.17 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 78 | 0.17 | Why? |
| Catechin | 1 | 2021 | 244 | 0.17 | Why? |
| Bifidobacterium | 1 | 2017 | 52 | 0.17 | Why? |
| Anti-Glomerular Basement Membrane Disease | 1 | 2017 | 31 | 0.17 | Why? |
| Genomics | 3 | 2018 | 3118 | 0.16 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.16 | Why? |
| Sequence Analysis, Protein | 1 | 2017 | 309 | 0.15 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.15 | Why? |
| Genetic Variation | 2 | 2021 | 3919 | 0.15 | Why? |
| Reassortant Viruses | 1 | 2017 | 287 | 0.15 | Why? |
| Hydrogen Bonding | 1 | 2017 | 599 | 0.15 | Why? |
| Biological Evolution | 1 | 2021 | 641 | 0.15 | Why? |
| Saccharomyces cerevisiae | 1 | 2017 | 339 | 0.15 | Why? |
| Protein Interaction Maps | 2 | 2021 | 1333 | 0.14 | Why? |
| Genome, Bacterial | 1 | 2018 | 446 | 0.14 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.14 | Why? |
| Genome | 1 | 2017 | 341 | 0.14 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.13 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2017 | 422 | 0.13 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.12 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.12 | Why? |
| Viral Proteins | 3 | 2021 | 7370 | 0.12 | Why? |
| Gene Expression Profiling | 3 | 2019 | 3788 | 0.11 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.11 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.10 | Why? |
| Lymphocyte Subsets | 1 | 2017 | 987 | 0.10 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.10 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Proteins | 1 | 2017 | 921 | 0.10 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.10 | Why? |
| Software | 2 | 2019 | 2501 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Orthomyxoviridae | 1 | 2017 | 1168 | 0.09 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2021 | 8843 | 0.09 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.09 | Why? |
| Molecular Sequence Annotation | 2 | 2021 | 478 | 0.08 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.08 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.08 | Why? |
| SARS Virus | 2 | 2021 | 13021 | 0.08 | Why? |
| China | 5 | 2021 | 50654 | 0.08 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.08 | Why? |
| Protein Interaction Mapping | 2 | 2019 | 487 | 0.07 | Why? |
| DNA, Viral | 1 | 2016 | 2521 | 0.07 | Why? |
| Computer Simulation | 2 | 2017 | 4982 | 0.07 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Animals | 8 | 2020 | 78931 | 0.06 | Why? |
| Models, Theoretical | 2 | 2020 | 6659 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Algorithms | 4 | 2020 | 7346 | 0.05 | Why? |
| Early Growth Response Protein 2 | 1 | 2019 | 1 | 0.05 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Time-Lapse Imaging | 1 | 2019 | 28 | 0.05 | Why? |
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 28 | 0.05 | Why? |
| Humans | 19 | 2021 | 930598 | 0.05 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2019 | 40 | 0.05 | Why? |
| Tropism | 1 | 2020 | 210 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Homeodomain Proteins | 1 | 2019 | 93 | 0.05 | Why? |
| Genetic Techniques | 1 | 2019 | 79 | 0.05 | Why? |
| Fluorescence Resonance Energy Transfer | 1 | 2021 | 320 | 0.05 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2019 | 159 | 0.05 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2019 | 91 | 0.05 | Why? |
| Viral Nonstructural Proteins | 1 | 2017 | 4810 | 0.05 | Why? |
| Oocytes | 1 | 2019 | 86 | 0.05 | Why? |
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 2 | 0.05 | Why? |
| Pyroptosis | 1 | 2020 | 168 | 0.05 | Why? |
| Medical History Taking | 1 | 2020 | 350 | 0.04 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2020 | 635 | 0.04 | Why? |
| Skin Physiological Phenomena | 1 | 2017 | 27 | 0.04 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.04 | Why? |
| Gene Ontology | 1 | 2019 | 391 | 0.04 | Why? |
| Color | 1 | 2017 | 92 | 0.04 | Why? |
| Mice | 4 | 2017 | 21357 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Mutagenesis, Insertional | 1 | 2017 | 92 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Antigens, Surface | 1 | 2017 | 181 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2019 | 469 | 0.04 | Why? |
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2017 | 140 | 0.04 | Why? |
| Immunity, Heterologous | 1 | 2017 | 129 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Adoptive Transfer | 1 | 2017 | 250 | 0.04 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.04 | Why? |
| HLA-DRB1 Chains | 1 | 2017 | 196 | 0.04 | Why? |
| Chromatography, Liquid | 1 | 2019 | 640 | 0.04 | Why? |
| Virulence Factors | 1 | 2018 | 338 | 0.04 | Why? |
| Genes, Viral | 1 | 2021 | 1428 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.03 | Why? |
| RNA, Long Noncoding | 1 | 2019 | 408 | 0.03 | Why? |
| Cross Protection | 1 | 2017 | 373 | 0.03 | Why? |
| DNA Methylation | 1 | 2019 | 688 | 0.03 | Why? |
| Microbial Viability | 1 | 2018 | 406 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2020 | 693 | 0.03 | Why? |
| HEK293 Cells | 2 | 2019 | 8394 | 0.03 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2019 | 1031 | 0.03 | Why? |
| Databases, Protein | 1 | 2017 | 523 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| History, 21st Century | 1 | 2020 | 1849 | 0.03 | Why? |
| Leukemia | 1 | 2017 | 598 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2017 | 952 | 0.03 | Why? |
| Models, Immunological | 1 | 2017 | 727 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.03 | Why? |
| Ferrets | 1 | 2017 | 1201 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.03 | Why? |
| A549 Cells | 1 | 2017 | 2066 | 0.03 | Why? |
| Databases, Genetic | 1 | 2017 | 1127 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Vasculitis | 1 | 2017 | 691 | 0.03 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.03 | Why? |
| Membrane Proteins | 1 | 2020 | 1733 | 0.02 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Virus Replication | 2 | 2021 | 14331 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2019 | 2450 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Coronavirus | 1 | 2018 | 18339 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Medicine, Chinese Traditional | 1 | 2021 | 2255 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2018 | 37182 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.02 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.02 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Female | 4 | 2021 | 380317 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |